General Information of Drug (ID: DM9S3P7)

Drug Name
PF-06473871
Indication
Disease Entry ICD 11 Status REF
Hypertrophic scars EE60 Phase 2 [1]
Drug Type
Antisense oligonucleotide
Cross-matching ID
TTD ID
D2AYS0

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
CCN2 messenger RNA (CCN2 mRNA) TTIL516 CCN2_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT02205476) A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study. U.S. National Institutes of Health.
2 A Placebo-controlled Study of PF-06473871 (Anti-Connective Tissue Growth Factor Antisense Oligonucleotide) in Reducing Hypertrophic Skin Scarring. Plast Reconstr Surg Glob Open. 2018 Sep 6;6(9):e1861.